Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors

Update your browser to view ScienceDirect.

Request details:

Request ID: 8db09f7f798215a8-LAX
IP: 116.62.10.13
UTC time: 2024-10-31T03:40:19+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4